Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir.
Saved in:
| Title: | Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir. |
|---|---|
| Authors: | Bai, Francesca1 (AUTHOR) francesca.bai@asst-santipaolocarlo.it, Beringheli, Tomaso1 (AUTHOR), Vitaletti, Virginia1 (AUTHOR), Santoro, Andrea1 (AUTHOR), Molà, Francesco1 (AUTHOR), Copes, Alessandro1 (AUTHOR), Gemignani, Nicole1 (AUTHOR), Pettenuzzo, Sofia1 (AUTHOR), Castoldi, Roberto1 (AUTHOR), Varisco, Benedetta1 (AUTHOR), Nardo, Riccardo1 (AUTHOR), Lundgren, Lorenzo Brando1 (AUTHOR), Ligresti, Riccardo1 (AUTHOR), Sala, Matteo1 (AUTHOR), Albertini, Lorenzo1 (AUTHOR), Augello, Matteo1 (AUTHOR), Biasioli, Lorenzo1 (AUTHOR), Bono, Valeria1 (AUTHOR), Rovito, Roberta1 (AUTHOR), Bini, Teresa1 (AUTHOR) |
| Source: | Infectious Diseases & Therapy. Jul2024, Vol. 13 Issue 7, p1589-1605. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
